A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222

NCT05426343 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Vaccine

Interventions

BIOLOGICAL: MVC-COV1901
BIOLOGICAL: AZD1222

Sponsor

Medigen Vaccine Biologics Corp.